Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Fleming

Showing results (201-210 of 219) with videos related to

Pageof 22
Sort By:
Clinical Transplantation|June 5, 2014
The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis CKathryn A Morbitzer, David J Taber, Nicole A Pilch, et al.
Journal of the American College of Surgeons|January 9, 2018
Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease ExceptionsJames N Fleming, David J Taber, Nicole A Pilch, et al.
Pharmacotherapy|December 21, 2016
Development of a Predictive Model for Drug-Related Problems in Kidney Transplant RecipientsKelly L Covert, Caitlin R Mardis, James N Fleming, et al.
Oncogene|March 22, 2016
The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2I Roth, H Campbell, C Rubio, et al.
Journal of Medicinal Chemistry|November 5, 1997
Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogsP H Reggio, T Wang, A E Brown, et al.
Plos One|October 10, 2009
Effect of DLK1 and RTL1 but not MEG3 or MEG8 on muscle gene expression in Callipyge lambsJolena N Fleming-Waddell, Gayla R Olbricht, Tasia M Taxis, et al.
Pharmacotherapy|May 6, 2017
Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant RecipientsJillian P Casale, Dave J Taber, Carmelina Staino, et al.
American Journal of Nephrology|September 25, 2013
Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients?David J Taber, Titte M Srinivas, Nicole A Pilch, et al.
Transplantation|June 29, 2017
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney TransplantationDavid J Taber, Zemin Su, James N Fleming, et al.
Transplantation|September 21, 2017
Liver Transplantation in the Obese Cirrhotic PatientErin K Spengler, Jacqueline G O'Leary, Helen S Te, et al.
Pageof 22

Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Clinical Transplantation|June 5, 2014
The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis CKathryn A Morbitzer, David J Taber, Nicole A Pilch, et al.
Journal of the American College of Surgeons|January 9, 2018
Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease ExceptionsJames N Fleming, David J Taber, Nicole A Pilch, et al.
Pharmacotherapy|December 21, 2016
Development of a Predictive Model for Drug-Related Problems in Kidney Transplant RecipientsKelly L Covert, Caitlin R Mardis, James N Fleming, et al.
Oncogene|March 22, 2016
The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2I Roth, H Campbell, C Rubio, et al.
Journal of Medicinal Chemistry|November 5, 1997
Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogsP H Reggio, T Wang, A E Brown, et al.
Plos One|October 10, 2009
Effect of DLK1 and RTL1 but not MEG3 or MEG8 on muscle gene expression in Callipyge lambsJolena N Fleming-Waddell, Gayla R Olbricht, Tasia M Taxis, et al.
Pharmacotherapy|May 6, 2017
Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant RecipientsJillian P Casale, Dave J Taber, Carmelina Staino, et al.
American Journal of Nephrology|September 25, 2013
Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients?David J Taber, Titte M Srinivas, Nicole A Pilch, et al.
Transplantation|June 29, 2017
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney TransplantationDavid J Taber, Zemin Su, James N Fleming, et al.
Transplantation|September 21, 2017
Liver Transplantation in the Obese Cirrhotic PatientErin K Spengler, Jacqueline G O'Leary, Helen S Te, et al.
Pageof 22